Thousands of mRNAs are ELAVL1 targets, including factors fostering diverse cancer traits such as proliferation (cyclins A2, B1, D1, and E1), angiogenesis (HIF1a, PTGS2, and VEGFA), survival (BCL2 and MCL1), and invasion (MMP9 and SNAI1) [59,60]. The gene discussed is CCNA2; the disease is cancer.